Premium
IC‐P‐136: SYNTHESIS AND IN VIVO BRAIN PET EVALUATION OF 1‐METHYL‐4‐PIPERIDYL P‐ 18 [F]FLOUROBENZOATE (TRV6501): A BUTYRYLCHOLINESTERASE‐SPECIFIC RADIOLIGAND FOR ALZHEIMER'S DISEASE
Author(s) -
DeBay Drew R.,
Pottie Ian,
Reid Andrew G.,
Martin Earl,
Boulaouz Antoun,
Burrell Steve,
Bowen Chris V.,
Darvesh Sultan
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.4250
Subject(s) - butyrylcholinesterase , radioligand , in vivo , positron emission tomography , temporal cortex , neuroscience , alzheimer's disease , chemistry , pathology , medicine , psychology , acetylcholinesterase , disease , aché , biochemistry , biology , receptor , enzyme , microbiology and biotechnology
IC-P-136 SYNTHESIS AND IN VIVO BRAIN PET EVALUATION OF 1-METHYL-4-PIPERIDYL P-[F]FLOUROBENZOATE (TRV6501): A BUTYRYLCHOLINESTERASE-SPECIFIC RADIOLIGAND FOR ALZHEIMER’S DISEASE Drew R. DeBay, Ian Pottie, Andrew G. Reid, Earl Martin, Antoun Boulaouz, Steve Burrell, Chris V. Bowen, Sultan Darvesh, Dalhousie University, Halifax, NS, Canada; Mount Saint Vincent University, Halifax, NS, Canada; Nova Scotia Health Authority, Halifax, NS, Canada. Contact e-mail: drdebay@dal.ca